Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

325
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
325
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

281
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
281
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

576
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
576
Discharge Summary Forms01:31

Discharge Summary Forms

1.2K
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.2K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

343
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing updated and living meta-analyses Part 1: A methodological scoping review on methods for conducting meta-analyses in updated and living systematic reviews.

Journal of clinical epidemiology·2026
Same author

CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials.

The Lancet. Child & adolescent health·2026
Same author

SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols.

The Lancet. Child & adolescent health·2026
Same author

Enhancing Patient Understanding of Radiology Reports Through Large Language Model-Generated Summaries, Clickable Terms, and Artificial Intelligence Videos.

Journal of the American College of Radiology : JACR·2026
Same author

Review of breast arterial calcifications for cardiovascular disease risk prediction.

NPJ cardiovascular health·2026
Same author

CLEAR-AI: confounder-aware learning for equitable and accurate reasoning in AI for diagnosis.

Journal of medical imaging (Bellingham, Wash.)·2026
Same journal

Cholesterol-Lowering Treatment Blocks Epithelial-Mesenchymal Transition (EMT) Associated Invasiveness and Drug Resistance in Breast and Colorectal Adenocarcinoma Models.

Cancer medicine·2026
Same journal

Factors Associated With Optimal Patient-Clinician Communication Among Cancer Survivors.

Cancer medicine·2026
Same journal

Targeting Temozolomide-Resistant Glioblastoma: Therapeutic Potential of Neuronal Nitric Oxide Synthase Inhibitor.

Cancer medicine·2026
Same journal

SDC1 Knockdown Suppresses Malignant Phenotypes of Breast Cancer by Modulating the MAPK Signaling Pathway.

Cancer medicine·2026
Same journal

Sex-, Age-, Lifestyle-, and Comorbidity-Specific Reference Values for Serum Cytokines in the Dutch General Population: Results From the PROFILES Registry.

Cancer medicine·2026
Same journal

Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma.

Cancer medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
09:40

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

Published on: April 17, 2020

14.8K

Association Between Discharge Medications and Oncologic Post-Embolization-Syndrome-Related Outcomes.

Hanzhou Li1, John Moon1, Nathan Sim2

  • 1Department of Radiology and Imaging Sciences, Emory School of Medicine, Atlanta, Georgia, USA.

Cancer Medicine
|December 3, 2025
PubMed
Summary
This summary is machine-generated.

Discharging hepatocellular carcinoma patients with opioids, antiemetics, and steroids after TACE or TARE significantly reduces readmission and drug escalation risks. This supports comprehensive post-procedure pain management strategies in interventional oncology.

Keywords:
chemoembolizationhepatocellular carcinomaopioidspost‐embolization syndromeradioembolizationreadmission

Related Experiment Videos

Last Updated: Jan 9, 2026

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
09:40

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

Published on: April 17, 2020

14.8K

Area of Science:

  • Interventional Oncology
  • Hepatocellular Carcinoma Treatment
  • Oncology Pharmacology

Background:

  • Post-embolization syndrome following transarterial chemoembolization (TACE) and Yttrium-90 radioembolization (TARE) leads to significant patient morbidity.
  • Optimizing discharge prescriptions may standardize pain management and improve short-term outcomes after these procedures.

Purpose of the Study:

  • To investigate the impact of discharge prescriptions on short-term outcomes after TACE and TARE for hepatocellular carcinoma.
  • To determine if specific medications influence the incidence of drug escalation or hospital readmission.

Main Methods:

  • Retrospective cohort study of 3191 patients undergoing 3988 procedures for hepatocellular carcinoma (2009-2022).
  • Utilized Merative MarketScan Databases for patient data and outcomes.
  • Analyzed 7-day composite outcome of drug escalation or hospital readmission using multivariable logistic regression, adjusting for patient demographics and comorbidities.

Main Results:

  • Opioid prescriptions at discharge were associated with significantly lower odds of drug escalation or readmission for both TACE (aOR=0.17) and TARE (aOR=0.41).
  • Prescribing antiemetics and steroids was also linked to reduced escalation/readmission events, with specific associations varying by procedure type.

Conclusions:

  • Discharge prescriptions including opioids, antiemetics, and steroids may decrease post-procedural complications like drug escalation and readmission in hepatocellular carcinoma patients undergoing TACE or TARE.
  • These findings underscore the necessity of integrated pain management strategies in interventional oncology practice.
  • Consideration of these prescription patterns is warranted for future clinical practice guidelines.